Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer
Menopausal Review · 2025 · 24 (3) · 206-210
DOI: 10.5114/pm.2025.154681 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Menopausal Review, 2025. Verfasst von Tomasz Kubiatowski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
- Oncology Clinic with a Gynecological Oncology Subdivision of the University Hospital in Rzeszow, Poland.
- Department of Oncology, Radiotherapy and Translational Medicine, Rzeszow University, Poland.
Zitieren
APA
Kubiatowski, T., & Kalinka, E. (2025). Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer. Menopausal Review, 24(3), 206-210. https://doi.org/10.5114/pm.2025.154681
Vancouver
Kubiatowski T, Kalinka E. Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer. Menopausal Review. 2025;24(3):206-210. doi:10.5114/pm.2025.154681
BibTeX
@article{Kubiatowski2025,
author = {Kubiatowski, Tomasz and Kalinka, Ewa},
title = {Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer},
journal = {Menopausal Review},
year = {2025},
volume = {24},
number = {3},
pages = {206--210},
doi = {10.5114/pm.2025.154681}
}
EUVIMED